Data from Analysis of Cancer Tissue Proteins Generated from Novel Workflow  Could Lead to Improvement in the Clinical Management of Gynecological Cancers South Easton, MA, October 1, 2019  -- – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced the Company’s patented pressure cycling...

read more